Fedora Pharmaceuticals Inc.
Novel antimicrobial drug candidates targeting antimicrobial resistance
- Sector
- Biotech
- Headquarters
- EDMONTON, A0
- Founded
- 2011
- Latest Form D
- $895K, Jun 2025
- Total capital
- $1.1M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $1.1M
- 2 Form D · last Jun 2025
- 17 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 7
- 2 pending · first 2016
- Rank in peer group#213 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$895K
- Private capital raisedForm D · SEC · 1st filing$200K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#213 · top 15%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Christopher MicetichExecutive Officer, DirectorNamed in SEC Form D filings
- Leonard E PostDirectorNamed in SEC Form D filings
- Ronald OdynskDirectorNamed in SEC Form D filings
- Sarat MaharajDirectorNamed in SEC Form D filings
What it has protected
USPTO · 7 granted of 9- GrantedLactivicin Compounds, Their Preparation And Use As Antibacterial AgentsUSPTOUS 12,528,804
- GrantedPharmaceutical Compositions Comprising LTV-17 And Beta-lactamase Inhibitors And Their Use As Antibacterial AgentsUSPTOUS 11,998,533
- GrantedLactivicin Compounds, Their Preparation And Use As Antibacterial AgentsUSPTOUS 11,780,832
Show all 9 patent records
- Lactivicin Compounds, Their Preparation And Use As Antibacterial AgentsJan 20, 2026 · US 12,528,804Granted
- Pharmaceutical Compositions Comprising LTV-17 And Beta-lactamase Inhibitors And Their Use As Antibacterial AgentsJun 4, 2024 · US 11,998,533Granted
- Lactivicin Compounds, Their Preparation And Use As Antibacterial AgentsOct 10, 2023 · US 11,780,832Granted
- Bicyclic Compounds And Their Use As Antibacterial Agents And Beta-lactamase InhibitorsJan 28, 2020 · US 10,544,146Granted
- Bicyclic Compounds And Their Use As Antibacterial Agents And Beta-lactamase InhibitorsJul 24, 2018 · US 10,030,019Granted
- Bicyclic Compounds And Their Use As Antibacterial Agents And Beta-lactamase InhibitorsNov 29, 2016 · US 9,505,761Granted
- Bicyclic Compounds And Their Use As Antibacterial Agents And Betalactamase InhibitorsJul 19, 2016 · US 9,393,239Granted
- Lactivicin Compounds, Their Preparation And Use As Antibacterial AgentsApplication 63168406Pending
- Pharmaceutical Compositions Comprising LTV-17 and Beta-Lactamase Inhibitors and Their Use as Antibacterial AgentsApplication 63263963Pending
Related companies, and why
- Versanis BioSimilar federal contract value in Biotech · null in contracts
- Accuronix Therapeutics IncSimilar federal contract value in Biotech · null in contracts
- GENE SOLUTIONS LLCSimilar federal contract value in Biotech · null in contracts
- Dystrogen Therapeutics CorpSimilar federal contract value in Biotech · null in contracts
- BioTuring, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .